News

Sorin Group has posted net profit of EUR23.2m for the full year 2009, compared to net loss of EUR37.1m for the prior year priod. EBITDA was EUR99.4m, an

Reportedly, the safety and efficacy of Carbaglu was studied in 23 patients with NAGS who received the treatment for times ranging from six months to 21 years. In

Reportedly, Dicon has also shown to be effective in the treatment of irritable bowel syndrome (IBS). Ram Biotech said that Dicon’s combination herbal therapy (CHT) distinguishes it from

The new contracts support ReNeuron’s clinical trial activities by the manufacture of additional clinical-grade material (drug substance lots) and the provision of manufacturing process validation services. Gordon Sherriff,

mPEG Alcohols are the key raw materials for activated mPEG alcohols, which are extensively used for pegylation with biologic drugs and increasingly for peptides and small molecule pharmaceuticals.

ActiFlow is a non-product contact device, consisting of a vibratory drive and intelligent control unit. The ActiFlow device is bolted to the outside of the rear wall of

EBITDA pre exceptionals in the fourth quarter of 2009 was EUR144m, slightly high compared to EUR87m in the fourth quarter of 2008, which was dominated by the effects

Reme-Flu is Legacy Biotechnologies’ 2-part homeopathic flu remedy designed to help treat symptoms of the flu. Initially, Reme-Flu is expected to be offered on the website www.nutralegacy.com. In

Menveo is indicated for active immunization of adolescents (from 11 years of age) and adults at risk of exposure to Neisseria meningitidis groups A, C, W135 and Y,